At a 17 percent no-show rate, with 50 slots a day at $175 average reimbursement, a 3-pediatrician practice loses 1,870 visits and roughly $327,000 a year in direct revenue. Well-child gaps, vaccine slot economics, and the August-to-September back-to-school surge shape the numbers.
Sources: MGMA 2024 DataDive, AAP Bright Futures 2024, Medicaid CHIPRA quality measures.
Pediatric revenue per slot runs lower than adult primary care because of two structural facts. First, Medicaid covers a substantial share of pediatric visits (about 40 percent of US children are insured by Medicaid or CHIP per Kaiser Family Foundation 2024 reporting), and Medicaid pediatric rates run roughly 70 percent of commercial. Second, well-child visit codes (99381 to 99395) reimburse roughly 15 to 20 percent above brief sick visits (99213), but the mix typically favors sick visits 60 to 40 in volume terms. Blended reimbursement lands at $160 to $190 per slot for most pediatric practices.
A 3-pediatrician practice with 50 slots a day, 220 working days, at $175 per slot runs 11,000 scheduled visits a year. At the MGMA 2024 median 17 percent no-show rate, that is 1,870 missed visits and $327,250 in direct lost revenue. Add unrecovered fixed cost (the rooms, the MA salaries, the EHR seats) at roughly $40 per missed slot for a pediatric practice (slightly lower than adult primary care because pediatric room turnover is faster and shared spaces are more common), which adds $74,800. Add downstream care-gap loss (HEDIS-adolescent measures, immunization on-time rates, lead-screening completion) at roughly $50,000 for a Medicaid-mixed practice. Total annual exposure: about $452,000.
| Component | Annual amount | Method |
|---|---|---|
| Direct billed revenue lost | $327,250 | 1,870 missed slots x $175 blended pediatric rate |
| Unrecovered fixed cost | $74,800 | 1,870 slots x $40 fixed cost per slot |
| Downstream HEDIS / care gap (est.) | $50,000 | Pediatric quality measure underperformance |
| Total economic loss | $452,050 | Sum of three lines |
A no-show on a sick visit is a $90 to $130 loss. A no-show on a well-child visit is different. Well-child visits are the anchor for vaccine series timing, developmental screening, lead screening (per state mandate, typically age 1 and 2), anemia screening, and HEDIS / Medicaid CHIPRA quality measures. A missed well-child visit at age 2 can cascade into a delayed MMR booster, a missed lead screen, and downstream quality-score impact on the practice's NCQA recognition and Medicaid pay-for-performance bonus.
The AAP Bright Futures schedule sets 13 well-child visits between birth and age 6, plus annual visits to age 21. Missing one is rarely catastrophic in isolation, but pediatric practices that consistently miss the on-schedule completion threshold for HEDIS measures (W30 well-child in the first 30 months, W34 well-child age 3 to 6, AWC adolescent well-care) see direct dollar impact through Medicaid managed-care bonus tiers and commercial value-based contracts. Loss attribution to no-shows specifically (versus families that genuinely choose to skip) is hard to pin down. A conservative practice-level estimate is $40,000 to $80,000 a year for a Medicaid-mixed 3-pediatrician practice.
Pediatric volume and no-show rate move in opposite directions across the year. August and September are the biggest months for completed visits because of school physicals, sports clearances, and the AAP-recommended annual well-child timing for school-age children. No-show rates drop to roughly 12 to 14 percent in those months because the visits have an external deadline (the school sports form must be signed). October stays elevated for flu shot administration.
November and December are the difficult months. Families travel, reschedule, or simply forget. Well-child no-show rates climb to 22 to 25 percent in those months. Sick visit no-shows stay roughly flat because flu and RSV season drives same-day appointments where the patient is symptomatic and motivated to show. Most of the annual lost dollars accumulate in November to February, and most of the recovery comes from operational discipline during those months: tighter reminder cadence, opportunistic same-day rebooking, and a December well-child push for families who can fit a year-end visit before their commercial deductible resets.
Practices that build a December campaign (we recommend a 3-touch SMS sequence at 21, 7, and 1 days) targeted at incomplete W30 / W34 cohorts typically recover $15,000 to $30,000 of late-year revenue and protect their HEDIS scores into the new measurement year. Mid-cycle adjustment is almost always worth the operational lift.
Standard SMS reminder ROI applies on top of the pediatric-specific tactics. See the SMS reminder ROI folio for the math.
Within a pediatric practice the rate is not uniform. Infant and toddler well-child visits run 12 to 14 percent no-shows (parents are highly motivated, schedule is dense). School-age (5 to 12) sits at the practice median, around 17 percent. Adolescents (13 to 18) sit at 22 to 26 percent for routine visits, with sub-cohorts (Medicaid adolescents, behavioral health follow-ups) climbing to 30 percent or higher.
The drivers for adolescent no-shows differ from infant or school-age. Adolescents have competing time demands (after-school work, sports, social), reduced parental escort, lower personal motivation for routine care, and frequent ambivalence about sensitive topics (mental health screening, sexual health, substance use). Practices with a meaningful adolescent panel benefit from adolescent-direct SMS reminders (with parent CC), adolescent-friendly scheduling windows (late afternoon, Saturday morning), and integrated behavioral health screening that reduces visit-skipping due to embarrassment.
HIPAA permits direct adolescent SMS in most states from age 12 to 14 onward for general appointment reminders. See the HIPAA text reminder folio for the consent and minor-rule details.
Register entries verified 2026-04-28